Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2010
09/30/2010US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function
09/30/2010US20100247448 Novel lanthanide ligands and complexes, and use thereof as contrast agents
09/30/2010US20100246363 Squarylium compound, optical recording medium using the same, recording/reproduction method and optical recording apparatus
09/30/2010US20100245217 Carbazole derivative, light-emitting element material, light-emitting element, light-emitting device, electronic device, and lighting device
09/30/2010US20100244672 Heterocyclic Compound, and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Appliance Using Heterocyclic Compound
09/30/2010US20100243959 Derivative With Heteroaromatic Ring, and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using Derivative With Heteroaromatic Ring
09/30/2010CA2756255A1 Substituted bicyclic hcv inhibitors
09/30/2010CA2756172A1 Inhibitors of hepatitis c virus replication
09/30/2010CA2755950A1 Useful pharmaceutical salts of 7-[(3r,4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one
09/30/2010CA2755348A1 Antiviral compounds and uses thereof
09/30/2010CA2755023A1 Antiviral compounds and uses thereof
09/30/2010CA2660962A1 Novel pharmaceutical composition for treatment of schizophrenia
09/30/2010CA2660954A1 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
09/29/2010EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation.
09/29/2010EP2233472A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
09/29/2010EP2233470A1 Histamine H3 receptor antagonists
09/29/2010EP2231680A2 Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof
09/29/2010EP2231679A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
09/29/2010EP2231649A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/29/2010EP2231641A2 Quinoxaline and quinoline derivatives as kinase inhibitors
09/29/2010EP2231640A1 Beta-amino acid derivatives for treatment of diabetes
09/29/2010EP2231636A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
09/29/2010EP2231629A1 Modulators for amyloid beta
09/29/2010EP2231620A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
09/29/2010EP2231615A1 Cannabinoid receptor modulators
09/29/2010EP2231280A2 Organic compounds
09/29/2010EP2231161A1 A process of making imatinib
09/29/2010EP2044058B1 Chemical compounds
09/29/2010EP2004641B1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
09/29/2010EP1658281B1 A method of removing the triphenylmethane protecting group
09/29/2010EP1638957B1 N-heterocyclyl phenyl-substituted cyclic ketoenols
09/29/2010EP1628957B1 Sulfopyrroles
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010EP1086950B1 Heterocyclic indole derivatives and mono- or diazaindole derivatives
09/29/2010CN101848898A Phthalazinone derivatives as inhibitors of PARP-1
09/29/2010CN101848897A Gamma secretase modulators
09/29/2010CN101848896A Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
09/29/2010CN101848882A 电致发光器件 Electroluminescent devices
09/29/2010CN101845023A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
09/29/2010CN101323611B Polar sensitive fluorescent probe compounds for arginine residue marker, preparation and use thereof
09/29/2010CN101228137B Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists
09/29/2010CN101074227B Phosphine acyloxy quinazoline derivatives and their medicine uses
09/29/2010CN101072771B Cgrp receptor antagonists
09/29/2010CN101006082B Histamine H3 receptor agents, preparation and therapeutic uses
09/28/2010US7803954 Mandelic acid derivatives and their use as thrombin inhibitors
09/28/2010US7803944 Viral polymerase inhibitors
09/28/2010US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
09/28/2010US7803832 N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides
09/28/2010US7803831 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer
09/28/2010US7803820 Schizophrenia; bioavailability, solubility, brain penetrancy; in vivo half life; synthesis; such as 3-[3-({4-methyl-5-[4-(pentafluoro-6-sulfanyl)phenyl]-4H-1,2,4-triazol-3-yl}thio)propyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane
09/28/2010US7803819 dipeptidyl peptidase IV (DPP-IV) inhibitors, such as 2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile, useful for the treatment and/or prophylaxis non-insulin dependent diabetes and impaired glucose tolerance; antidiabetic agents
09/28/2010US7803816 Melanin-concentrating hormone (MCH) receptor antagonists, such as (S)-2-{(3R,4R)-4-[6-Fluoro-2-(1-hydroxy-1-methyl-ethyl)-5-methyl-benzoimidazol-1-yl]-3 methoxy-piperidin-1-ylmethyl}-indan-5-carbonitrile, useful as dietetics, anxiolytic agents, antidepressants and anorexigenic agents
09/28/2010US7803815 Indol-3-yl-corbonyl-piperidin-benzoimidazol derivatives
09/28/2010US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
09/28/2010US7803795 and nitric oxide synthase inhibitor; e.g. 1-(phenylmethyl)-4-piperidyl-6-phthalazine-3one; antiinflammatory agent; preserve the cellular energy level: survival of ischaemic tissues after insult; neurodegenerative diseases: stroke, Alzheimer's and Parkinson's diseases, atherosclerosis, osteoarthritis
09/28/2010CA2527587C Heteroaryl-substituted imidazole derivatives as glutamate receptor antagonists
09/28/2010CA2504614C Process for the preparation of imidazolyl compounds
09/28/2010CA2387016C Acrylamide derivatives as fab i inhibitors
09/23/2010WO2010107809A2 Methods for preparing dpp-iv inhibitor compounds
09/23/2010WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010WO2010107765A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010WO2010106551A2 A process for the manufacture of pure anhydrous aripiprazole form b
09/23/2010WO2010106290A1 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
09/23/2010WO2010106269A2 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010WO2010106097A1 Substituted pyrimidines for the treatment of cancer
09/23/2010WO2010083872A3 Materials for organic electroluminescence devices
09/23/2010WO2009132774A8 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors
09/23/2010US20100240892 Electroluminescent device
09/23/2010US20100240888 salts of bazedoxifene
09/23/2010US20100240720 Allosteric jnk inhibitors
09/23/2010US20100240686 Chemical compounds
09/23/2010US20100240671 Substituted heterocyclic compounds
09/23/2010US20100240657 Chemical compounds
09/23/2010US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
09/23/2010US20100240642 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators
09/23/2010US20100240640 (THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100240636 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists
09/23/2010US20100240618 Substituted piperazines
09/23/2010US20100240611 Methods for preparing dpp-iv inhibitor compounds
09/23/2010US20100239525 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
09/23/2010US20100239500 Substituted triazine compounds for nerve regeneration
09/23/2010US20100237339 Carbazole Derivative with Heteroaromatic Ring, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Carbazole Derivative with Heteroaromatic Ring
09/23/2010CA2755759A1 Substituted pyrimidines for the treatment of cancer
09/23/2010CA2755660A1 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
09/23/2010CA2755526A1 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010CA2755251A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010CA2754509A1 Novel anti-inflammatory agents
09/22/2010EP2230230A1 Substituted dihydroazole compound and pest control agent
09/22/2010EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
09/22/2010EP2229381A1 Gamma secretase modulators
09/22/2010EP2229380A1 Polymorphic forms of a 3-pyrrole substituted 2-indolinone
09/22/2010EP2229375A1 Gamma secretase modulators
09/22/2010EP2229358A1 Indoles and their therapeutic use
09/22/2010EP2229356A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
09/22/2010EP2021330B1 Benzimidazole modulators of vr1
09/22/2010EP1836163B1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 626